PHASE II STUDY OF CLOFARABINE IN COMBINATION WITH CYTARABINE AND LIPOSOMAL DOXORUBICIN IN CHILDREN WITH EITHER LYMPHOBLASTIC OR MYELOID RELAPSE OR REFRACTORY ACUTE LEUKEMIA AND IN CHILDREN WITH SECONDARY ACUTE MYELOID LEUKEMIA STUDIO DI FASE II SULL'UTILIZZO DI CLOFARABINA IN COMBINAZIONE CON CITARABINA E DOXORUBICINA LIPOSOMIALE IN PAZIENTI PEDIATRICI CON DIAGNOSI DI LEUCEMIA LINFOBLASTICA ACUTA E LEUCEMIA MIELOIDE ACUTA IN RECIDIVA O REFRATTARIA O DI LEUCEMIA MIELOIDE ACUTA SECONDARIA

Trial Profile

PHASE II STUDY OF CLOFARABINE IN COMBINATION WITH CYTARABINE AND LIPOSOMAL DOXORUBICIN IN CHILDREN WITH EITHER LYMPHOBLASTIC OR MYELOID RELAPSE OR REFRACTORY ACUTE LEUKEMIA AND IN CHILDREN WITH SECONDARY ACUTE MYELOID LEUKEMIA STUDIO DI FASE II SULL'UTILIZZO DI CLOFARABINA IN COMBINAZIONE CON CITARABINA E DOXORUBICINA LIPOSOMIALE IN PAZIENTI PEDIATRICI CON DIAGNOSI DI LEUCEMIA LINFOBLASTICA ACUTA E LEUCEMIA MIELOIDE ACUTA IN RECIDIVA O REFRATTARIA O DI LEUCEMIA MIELOIDE ACUTA SECONDARIA

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2014

At a glance

  • Drugs Clofarabine (Primary) ; Cytarabine; Doxorubicin liposomal
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Acronyms CLA-MYOCET
  • Most Recent Events

    • 03 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top